The Association Between Proton Pump Inhibitors and Clostridium Difficile Infection: Reducing Risk

The Association Between Proton Pump Inhibitors and Clostridium Difficile Infection: Reducing Risk

Identification: MSNN1506
Issue: November/December 2015
Volume: Volume 24 - Number 6
Credits (Post Test and/or Evaluation Required)
Available until 12/31/2017
  • 1.00 - CH
  • 0.00 - Rx

Standard: $20.00

Description

Contact hours available until 12/31/2017.

Learning Outcome:
After completing this learning activity, the learner will be able to explain how to reduce risks associated with Clostridium difficile infection (CDI) with the use of proton pump inhibitors
(PPIs).

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Authors Conflict of Interest Disclosure:
The author(s), editor, editorial committee, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and AMSN.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC-COA)

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered nursing, Provider Number, CEP 5387.

This article was reviewed and formatted for contact hour credit by Rosemarie Marmion, MSN, RN-BC, NE-BC, AMSN Education Director.

Author(s)

Credits Available


The Association Between Proton Pump Inhibitors and Clostridium Difficile Infection: Reducing Risk

You must be logged in and own this product in order to post comments.